Efficacy of immunotherapy in small cell lung cancer: A retrospective stude

• Published in: Consilium medicum (Online) Vol. 26; no. 6; pp. 362 - 367
• Main Authors: Lyadova, Marina A., Fedorinov, Denis S., Mansurova, Julia S., Kuzmina, Evgeniya S., Esakov, Yury S., Lyadov, Konstantin V., Galkin, Vsevolod N., Poddubnaya, Irina V.
• Format: Journal Article
• Language: English; Russian
• Published: ZAO "Consilium Medicum" 30.08.2024
• Subjects: immune checkpoint inhibitors; immune-mediated adverse event; immunotherapy; safety profile; small cell lung cancer

Background. Small cell lung cancer (SCLC), predominantly due to smoking, is a highly differentiated, rapidly growing epithelial cell carcinoma of high malignancy originating from bronchial neuroendocrine cells. Almost 70% of SCLC patients have metastases at the time of diagnosis, which requires the...